The Role of Precision Medicine in Family Health: Tailoring Treatments for Hereditary Diseases

Authors

  • Rufus Oluwagbemileke Ajayi Department of Public Health, University of Illinois at Springfield, USA
  • Oluwafikayo Seun Adeyemi-Benson Department of Public Health, University of Illinois at Springfield, USA
  • Oluwateniola Ajoke Adeyemi-Benson Department of Biochemistry, Ladoke Akintola University of Technology, Nigeria
  • Taiwo Temitope Ogunjobi Department of Biochemistry, Ladoke Akintola University of Technology, Nigeria
  • Onyeka Mary Ukpoju-Ebonyi Department of Public Health, University of Illinois at Springfield, USA
  • Jean-Marie Akor Ebonyi Department of Public Health, University of Illinois at Springfield, USA https://orcid.org/0009-0002-0382-3718

DOI:

https://doi.org/10.47852/bonviewMEDIN52025796

Keywords:

precision medicine, hereditary diseases, genetic testing, targeted therapies, multi-omics, personalized healthcare

Abstract

Precision medicine is transforming the management of genetic disorders by facilitating personalized treatment approaches that enhance patient outcomes and tackle familial health issues. This study consolidates recent advancements in genetic testing, targeted pharmacological therapies, and individualized treatment strategies, concentrating on cystic fibrosis, sickle cell anemia, and familial hypercholesterolemia. Significant attention is directed toward the essential functions of early diagnosis, familial risk evaluation, and preventive measures to improve health-related quality of life. The review critically examines ongoing challenges, including healthcare disparities, ethical dilemmas, and data privacy concerns. Additionally, it examines the incorporation of emerging technologies, such as multi-omics platforms, artificial intelligence, and genome editing, as valuable tools to enhance diagnosis, therapy, and disease monitoring. The review highlights the potential of precision medicine to enhance sustainable healthcare systems by improving resource allocation, mitigating the long-term economic impacts of chronic genetic disorders, and promoting equitable access to innovative therapeutics. This review highlights the transformative potential of precision medicine in managing genetic disorders using CRISPR-Cas9 and its alignment with the Sustainable Development Goals, which aim to promote global health equity and personalized care.

 

Received: 29 March 2025 | Revised: 30 July 2025 | Accepted: 23 October 2025

 

Conflicts of Interest

The authors declare that they have no conflicts of interest to this work.

 

Data Availability Statement

The data that support this work are available upon reasonable request to the corresponding author.

 

Author Contribution Statement

Rufus Oluwagbemileke Ajayi: Conceptualization, Writing – original draft, Writing – review & editing. Oluwafikayo Seun Adeyemi-Benson: Conceptualization, Writing – original draft. Oluwateniola Ajoke Adeyemi-Benson: Methodology, Project administration. Taiwo Temitope Ogunjobi: Methodology, Writing – review & editing. Onyeka Mary Ukpoju-Ebonyi: Investigation. Jean-Marie Akor Ebonyi: Investigation.


Downloads

Published

2025-11-11

Issue

Section

Review

How to Cite

Ajayi, R. O., Adeyemi-Benson, . O. S., Adeyemi-Benson, O. A., Ogunjobi, T. T., Ukpoju-Ebonyi, O. M., & Ebonyi, J.-M. A. (2025). The Role of Precision Medicine in Family Health: Tailoring Treatments for Hereditary Diseases. Medinformatics. https://doi.org/10.47852/bonviewMEDIN52025796